Nezglyal

leriglitazone hydrochloride · Minoryx Therapeutics S.L.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nezglyal, covering 2024-11-20 to 2024-11-20. Get the full timeline:

Most recent: EMA Refused: Nezglyal (leriglitazone hydrochloride) — Minoryx Therapeutics S.L.